Abstract:Introduction: In human populations, telomere length (TL) displays a large inter-individual variability. At the population level, the most predictive variable for TL is age. Rare loss-of-function mutations in telomere maintenance genes are known to cause telomeropathies, a group of deadly diseases triggered by critically short telomeres. Over the last few decades, GWASs have uncovered many common variants associated with TL. More recently, a small number of PheWASs have suggested short-TL is associated with risk for a wide spectrum of phenotypes whereas long-TL is primarily associated with increased risk for several different neoplasms. We hypothesized that genetic variation contributing to long-TL may cause a unique and heritable telomeropathy, distinguishable from classical telomeropathies, that we refer to as a long-telomeropathy resulting in a cancer-like syndrome. To test this hypothesis, we studied telomere genetics in two large independent cohorts linking genomics with electronic health records data. Methods: Discovery cohort consisted of approximately 70,398 individuals from the All of Us (AoU) Research Program. Marshfield Clinic's PMRP Biobank of 19,443 individuals served as a replication set. Previously published GWAS results (161 common variant) were utilized to produce a weighted polygenic risk score for TL (TL-PRS). A PheWAS of TL-PRS in AoU identified 19 significant phenotypes that passed a Bonferroni-adjusted p-value threshold (P<2.71E-5). Notably, risk for all 19 phenotypes were associated with long-TL and were categorized as neoplasm or neoplasm-like phenotypes. PheWAS results were used to generate a phenotype risk score for long-telomeropathy (longTL-PheRS), and this model was replicated in PMRP. Results: The validated longTL-PheRS was used to screen rare variants that may contribute to increased risk for a telomere dependent cancer-like syndrome. When focusing on 293 telomere related genes in AoU, SKAT identified ATM (P=8.8E-7) and DCLRE1B (P<1E-10) as statistically significant risk genes. Whereas ATM has been previously implicated in multiple cancer types, DCLRE1B has not. SKAT results were influenced largely by a single missense variant in each gene [P=2.43E-15 (ATM, p.Leu2307Phe) and =1.78E-12 (DCLRE1B, p.Asn510Tyr)]. Neither variant was previously reported as pathogenic. Conclusion: Many decades of research in telomere biology has demonstrated the health consequences associated with telomere shortening. This study builds on a growing body of evidence that long telomeres also have significant negative health implications. Individuals who have a genetic predisposition to long telomeres influenced by both common and rare variants may be at risk for a spectrum of tumors. These findings may lead to new diagnostic or preventative measures for individuals at risk for a long-telomeropathy and a cancer-like syndrome. Citation Format: scott hebbring, Patrick Alaire. A phenotype risk score to define patients with a 'long-telomeropathy' and at risk for a novel cancer-like syndrome [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 1633.

Long-telomeropathy is associated with tumor predisposition syndrome

Abstract 1633: A phenotype risk score to define patients with a 'long-telomeropathy' and at risk for a novel cancer-like syndrome

Different phenotypes with different endings—Telomere biology disorders and cancer predisposition with long telomeres

Long Telomeres in Peripheral Blood Leukocytes Are Associated with an Increased Risk of Soft Tissue Sarcoma.

Discriminating Association of a Common Telomerase Reverse Transcriptase Promoter Polymorphism with Telomere Parameters in Non-Small Cell Lung Cancer with or Without Epidermal Growth Factor Receptor Mutation.

Whole exome sequencing analyses reveal novel genes in telomere length and their biomedical implications

Telomere length and cancer risk: finding Goldilocks

The impact of telomere length on prostate cancer aggressiveness, genomic instability and health disparities

Polygenic basis and biomedical consequences of telomere length variation

Epigenetic Inheritance of Telomere Length Obscures Identification of Causative PARN Locus.

Genomic, phenomic, and geographic associations of leukocyte telomere length in the United States

Leukocyte Telomere Length and Risk of Secondary Primary Tumors in Long-Term Breast Cancer Survivors

hTERT Cancer Risk Genotypes Are Associated With Telomere Length

Mendelian Randomization and Mediation Analysis of Leukocyte Telomere Length and Risk of Lung and Head and Neck Cancers

T Cell Immune Deficiency Rather Than Chromosome Instability Predisposes Patients with Short Telomere Syndromes to Squamous Cancers.

The causal effect of telomere length on the risk of malignant lymphoma: A Mendelian randomization study

Abstract 2745: Genetic Determinants of Telomere Length – a Genome Wide Association Study

Genetic Variants Related to Longer Telomere Length Are Associated with Increased Risk of Renal Cell Carcinoma

Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study

Exploring the Susceptibility to Multiple Primary Tumors in Patients with Differentiated Thyroid Cancer

Short telomere lengths in peripheral blood leukocytes are associated with an increased risk of oral premalignant lesion and oral squamous cell carcinoma.